ABCL
Price
$2.15
Change
-$0.06 (-2.73%)
Updated
Mar 11, 01:45 PM (EDT)
Capitalization
657.06M
63 days until earnings call
BTAI
Price
$2.49
Change
-$0.48 (-16.16%)
Updated
Mar 11, 02:20 PM (EDT)
Capitalization
9.17M
62 days until earnings call
Ad is loading...

ABCL vs BTAI

Header iconABCL vs BTAI Comparison
Open Charts ABCL vs BTAIBanner chart's image
AbCellera Biologics
Price$2.15
Change-$0.06 (-2.73%)
Volume$100
Capitalization657.06M
BioXcel Therapeutics
Price$2.49
Change-$0.48 (-16.16%)
Volume$1.32K
Capitalization9.17M
ABCL vs BTAI Comparison Chart
Loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BTAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABCL vs. BTAI commentary
Mar 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a Buy and BTAI is a Hold.

Ad is loading...
COMPARISON
Comparison
Mar 11, 2025
Stock price -- (ABCL: $2.20 vs. BTAI: $2.97)
Brand notoriety: ABCL and BTAI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 129% vs. BTAI: 23%
Market capitalization -- ABCL: $657.06M vs. BTAI: $9.17M
ABCL [@Biotechnology] is valued at $657.06M. BTAI’s [@Biotechnology] market capitalization is $9.17M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.07B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whileBTAI’s FA Score has 0 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • BTAI’s FA Score: 0 green, 5 red.
According to our system of comparison, ABCL is a better buy in the long-term than BTAI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 4 TA indicator(s) are bullish while BTAI’s TA Score has 5 bullish TA indicator(s).

  • ABCL’s TA Score: 4 bullish, 6 bearish.
  • BTAI’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, BTAI is a better buy in the short-term than ABCL.

Price Growth

ABCL (@Biotechnology) experienced а -6.78% price change this week, while BTAI (@Biotechnology) price change was -20.80% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.06%. For the same industry, the average monthly price growth was -9.70%, and the average quarterly price growth was -9.16%.

Reported Earning Dates

ABCL is expected to report earnings on May 13, 2025.

BTAI is expected to report earnings on May 12, 2025.

Industries' Descriptions

@Biotechnology (-1.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABCL($657M) has a higher market cap than BTAI($9.17M). ABCL YTD gains are higher at: -24.915 vs. BTAI (-50.354). ABCL has more cash in the bank: 643M vs. BTAI (233M). ABCL has less debt than BTAI: ABCL (71.4M) vs BTAI (105M).
ABCLBTAIABCL / BTAI
Capitalization657M9.17M7,168%
EBITDA-202.4MN/A-
Gain YTD-24.915-50.35449%
P/E RatioN/AN/A-
Revenue33MN/A-
Total Cash643M233M276%
Total Debt71.4M105M68%
FUNDAMENTALS RATINGS
BTAI: Fundamental Ratings
BTAI
OUTLOOK RATING
1..100
97
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
95
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABCLBTAI
RSI
ODDS (%)
Bullish Trend 8 days ago
77%
Bullish Trend 8 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 8 days ago
65%
Bullish Trend 8 days ago
89%
Momentum
ODDS (%)
Bearish Trend 8 days ago
83%
Bullish Trend 8 days ago
86%
MACD
ODDS (%)
Bearish Trend 8 days ago
90%
Bullish Trend 8 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 8 days ago
87%
Bullish Trend 8 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 8 days ago
88%
Bearish Trend 8 days ago
90%
Advances
ODDS (%)
Bullish Trend 22 days ago
77%
Bullish Trend 9 days ago
82%
Declines
ODDS (%)
Bearish Trend 8 days ago
85%
Bearish Trend 15 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 8 days ago
87%
Bearish Trend 8 days ago
90%
Aroon
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 8 days ago
88%
View a ticker or compare two or three
Ad is loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BTAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X78532.000000-2069.039000
-2.57%
Bitcoin cryptocurrency
SPY560.58-15.34
-2.66%
SPDR® S&P 500® ETF Trust
AAPL227.48-11.59
-4.85%
Apple
GME22.42-1.58
-6.58%
GameStop Corp
TSLA222.15-40.52
-15.43%
Tesla

ABCL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCL has been loosely correlated with CRSP. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCL jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCL
1D Price
Change %
ABCL100%
-5.58%
CRSP - ABCL
56%
Loosely correlated
-4.81%
NTLA - ABCL
55%
Loosely correlated
-8.60%
PRME - ABCL
53%
Loosely correlated
-13.33%
ABSI - ABCL
53%
Loosely correlated
-1.92%
BEAM - ABCL
52%
Loosely correlated
-9.80%
More

BTAI and

Correlation & Price change

A.I.dvisor indicates that over the last year, BTAI has been loosely correlated with TENX. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if BTAI jumps, then TENX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BTAI
1D Price
Change %
BTAI100%
-11.87%
TENX - BTAI
37%
Loosely correlated
-2.75%
SYBX - BTAI
37%
Loosely correlated
-4.18%
COGT - BTAI
33%
Poorly correlated
-2.28%
SBHMY - BTAI
32%
Poorly correlated
N/A
ABCL - BTAI
30%
Poorly correlated
-5.58%
More